Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

The quest for a cure in follicular lymphoma

Sanne H. Tonino, Marie José Kersten

Blood (2024) 143 (6): 475–476.

https://doi.org/10.1182/blood.2023022796

Published: 2024

Journal Articles

BRAF V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis

Blood (2023) 142 (18): 1570–1575.

https://doi.org/10.1182/blood.2023021212

Published: 2023

Includes: Supplemental data

Journal Articles

Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL

Blood (2023) 142 (13): 1131–1142.

https://doi.org/10.1182/blood.2023020195

Published: 2023

Includes: Supplemental data

Journal Articles

Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8 + T cells and impede CAR T-cell efficacy

Jaco A. C. van Bruggen, Anne W. J. Martens, Joseph A. Fraietta, Tom Hofland, Sanne H. Tonino, Eric Eldering, Mark-David Levin, Peter J. Siska, Sanne Endstra, Jeffrey C. Rathmell, Carl H. June, David L. Porter, J. Joseph Melenhorst, Arnon P. Kater, Gerritje J. W. van der Windt

Blood (2019) 134 (1): 44–58.

https://doi.org/10.1182/blood.2018885863

Published: 2019

Includes: Supplemental data

Journal Articles

Combining Brentuximab Vedotin with DHAP as Salvage Treatment in Relapsed/Refractory Hodgkin Lymphoma: The Phase II HOVON/LLPC Transplant BRaVE study

Anton Hagenbeek, MD PhD, Josée M Zijlstra, MD, Wouter J Plattel, MD, Franck Morschhauser, MD, Petronella J Lugtenburg, MD PhD, Pauline Brice, MD, Martin Hutchings, MD, Thomas Gastinne, MD, Roberto D Liu, Coreline N Burggraaf, MD, Marcel Nijland, MD, Sanne H Tonino, MD PhD, Harm van Tinteren, MSc, Marta I Lopez Yurda, MSc, Marie José Kersten, MD PhD

Blood (2018) 132 (Supplement 1): 2923.

https://doi.org/10.1182/blood-2018-99-112235

Published: 2018

Journal Articles

Improving CLL Vγ9Vδ2-T–cell fitness for cellular therapy by ex vivo activation and ibrutinib

Iris de Weerdt, Tom Hofland, Roeland Lameris, Sanne Endstra, Aldo Jongejan, Perry D. Moerland, Renee C. G. de Bruin, Ester B. M. Remmerswaal, Ineke J. M. ten Berge, Nora Liu, Mario van der Stelt, Laura M. Faber, Mark-David Levin, Eric Eldering, Sanne H. Tonino, Tanja D. de Gruijl, Hans J. van der Vliet, Arnon P. Kater

Blood (2018) 132 (21): 2260–2272.

https://doi.org/10.1182/blood-2017-12-822569

Published: 2018

Includes: Supplemental data

Journal Articles

EBV-Specific CD8 + T-Cells Are Not Functionally Impaired in Chronic Lymphocytic Leukemia

Tom Hofland, Iris de Weerdt, Sanne Terpstra, Ester B.M. Remmerswaal, PhD, Ineke J.M. ten Berge, MD PhD, Arnon P. Kater, MD PhD, Sanne H. Tonino, MD PhD

Blood (2015) 126 (23): 1723.

https://doi.org/10.1182/blood.V126.23.1723.1723

Published: 2015

Journal Articles

Chronic Lymphocytic Leukemia (CLL) Cells Are Susceptible to γδ-T Cell Mediated Killing, Provided CLL-Derived γδ-T Cell Dysfunction Can be Reversed

Iris de Weerdt, Sanne Terpstra, Tom Hofland, Roeland Lameris, MD, Renee C.G. de Bruin, Mark-David Levin, MDPhD, Ester B.M. Remmerswaal, PhD, Ineke J.M. ten Berge, MD PhD, Sanne H. Tonino, MD PhD, Tanja D de Gruijl, PhD, Hans van der Vliet, MD PhD, Arnon P. Kater, MD PhD

Blood (2015) 126 (23): 2914.

https://doi.org/10.1182/blood.V126.23.2914.2914

Published: 2015

Journal Articles

How does lenalidomide target the chronic lymphocytic leukemia microenvironment?

Arnon P. Kater, Sanne H. Tonino, Alexander Egle, Alan G. Ramsay

Blood (2014) 124 (14): 2184–2189.

https://doi.org/10.1182/blood-2014-05-578286

Published: 2014

Includes: Supplemental data

Journal Articles

CMV-specific CD8 + T-cell function is not impaired in chronic lymphocytic leukemia

G. Doreen te Raa, Maria Fernanda Pascutti, Juan J. García-Vallejo, Emilie Reinen, Ester B. M. Remmerswaal, Ineke J. M. ten Berge, René A. W. van Lier, Eric Eldering, Marinus H. J. van Oers, Sanne H. Tonino, Arnon P. Kater

Blood (2014) 123 (5): 717–724.

https://doi.org/10.1182/blood-2013-08-518183

Published: 2014

Includes: Supplemental data

Journal Articles

Interim Analysis Of Dose-Escalation Stage Of a Phase 1b Study Evaluating Safety and Pharmacology Of GS-9820, a Second-Generation, Selective, PI3Kd-Inhibitor in Recurrent Lymphoid Malignancies

Arnon P. Kater, MD PhD, Sanne H. Tonino, MD, PhD, Marie Jose Kersten, MD, PhD, Anton Hagenbeek, MD, PhD, Marjolein Spiering, Msc, Marinus H van Oers, MD PhD, Yan Xin, PhD, Srinivasan Ramanathan, PhD, Maria Aiello, MA, Susie Jun, MD, PhD

Blood (2013) 122 (21): 2881.

https://doi.org/10.1182/blood.V122.21.2881.2881

Published: 2013

Journal Articles

CMV-Specific CD8 + T-CELL Function Is NOT Impaired In CLL

Doreen te Raa, MD, Fernanda Pascutti, PhD, Juan J Garcia-Vallejo, PhD, Emilie Reinen, Ester B.M. Remmerswaal, René A.W. Van Lier, PhD, Eric Eldering, PhD, Marinus H.J. Van Oers, MD, PhD, Sanne H. Tonino, MD PhD, Arnon P. Kater, MD PhD

Blood (2013) 122 (21): 2862.

https://doi.org/10.1182/blood.V122.21.2862.2862

Published: 2013

Journal Articles

The Broad Kinase Inhibitor Dasatinib in Combination with Fludarabine in Patients with Refractory Chronic Lymphocytic Leukemia: A Multicenter Phase 2 Study

Arnon P. Kater, MD PhD, Marjolijn Spiering, Rob D Liu, Marielle M Beckers, Sanne H. Tonino, Simon M. G. J. Daenen, Jeanette K Doorduijn, Nienke A Lankheet, Dieuwertje M Luijks, Doreen te Raa, MD, Eric Eldering, PhD, Marinus H.J. Van Oers, MD, PhD

Blood (2012) 120 (21): 1798.

https://doi.org/10.1182/blood.V120.21.1798.1798

Published: 2012

Journal Articles

ROS-Mediated Upregulation of Noxa Overcomes Drug-Resistance Due to P53-Dysfunction in Chronic Lymphocytic Leukemia.

Sanne H. Tonino, Jacoline M van Laar, Marinus H. J. van Oers, Jean Y.J. Wang, PhD, Eric Eldering, Arnon P. Kater, MD, PhD

Blood (2009) 114 (22): 2382.

https://doi.org/10.1182/blood.V114.22.2382.2382

Published: 2009

Journal Articles

R-DHAP Is Effective in Fludarabine-Refractory CLL, Possibly Via Upregulation of Pro-Apoptotic P73.

Sanne H. Tonino, Michel Van Gelder, MD, PhD, Eric Eldering, Marinus H. J. van Oers, Arnon P. Kater, MD, PhD

Blood (2009) 114 (22): 3449.

https://doi.org/10.1182/blood.V114.22.3449.3449

Published: 2009

Journal Articles

Dichotomy in NF-κb Signaling and Chemoresistance in IgV H Mutated Versus Unmutated CLL Cells Revealed by CD40Ligand/CpG Stimulation

Jacqueline Tromp, Sanne H. Tonino, Marinus H.J. Van Oers, MD, PhD, Eric Eldering

Blood (2008) 112 (11): 542.

https://doi.org/10.1182/blood.V112.11.542.542

Published: 2008

Journal Articles

Platinum-Based Compounds Induce Expression of p73 and Restores Drug- Sensitivity in p53 Dysfunctional Chronic Lymphocytic Leukemia (CLL) Cells.

Sanne H. Tonino, MD, Chantal Mulkens, Yoshinori Nonomura, MD, Guangli Suo, MD, Thomas J. Kipps, MD, PhD, Marinus H.J. van Oers, MD, PhD, Eric Eldering, MD, Arnon P. Kater, MD, PhD

Blood (2008) 112 (11): 2102.

https://doi.org/10.1182/blood.V112.11.2102.2102

Published: 2008

Journal Articles

No convincing evidence for a role of CD31-CD38 interactions in the pathogenesis of chronic lymphocytic leukemia

Sanne H. Tonino, Rene Spijker, Dieuwertje M.P. Luijks, Marinus H. J. van Oers, Arnon P. Kater

Blood (2008) 112 (3): 840–843.

https://doi.org/10.1182/blood-2008-03-144576

Published: 2008

Journal Articles

CMV-Associated Expansion of CD8 + CD45RA + CD27 − T-Cells in Patients with B-Cell Malignancies.

Sanne H. Tonino, MD, Marinus H.J. Van Oers, MD, PhD, Rene A. Van Lier, MD, PhD, Marie Jose Kersten, MD, PhD

Blood (2007) 110 (11): 3592.

https://doi.org/10.1182/blood.V110.11.3592.3592

Published: 2007

Journal Articles

CD31-CD38 Interaction Has No Major Role in the Pathogenesis of CLL.

Sanne H. Tonino, MD, Rene Spijker, Marinus H.J. Van Oers, MD, PhD, Arnon P. Kater, MD, PhD

Blood (2007) 110 (11): 1139.

https://doi.org/10.1182/blood.V110.11.1139.1139

Published: 2007

NARROW

The quest for a cure in follicular lymphoma

BRAF V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis

Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL

Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8 + T cells and impede CAR T-cell efficacy

Combining Brentuximab Vedotin with DHAP as Salvage Treatment in Relapsed/Refractory Hodgkin Lymphoma: The Phase II HOVON/LLPC Transplant BRaVE study

Improving CLL Vγ9Vδ2-T–cell fitness for cellular therapy by ex vivo activation and ibrutinib

EBV-Specific CD8 + T-Cells Are Not Functionally Impaired in Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia (CLL) Cells Are Susceptible to γδ-T Cell Mediated Killing, Provided CLL-Derived γδ-T Cell Dysfunction Can be Reversed

How does lenalidomide target the chronic lymphocytic leukemia microenvironment?

CMV-specific CD8 + T-cell function is not impaired in chronic lymphocytic leukemia

Interim Analysis Of Dose-Escalation Stage Of a Phase 1b Study Evaluating Safety and Pharmacology Of GS-9820, a Second-Generation, Selective, PI3Kd-Inhibitor in Recurrent Lymphoid Malignancies

CMV-Specific CD8 + T-CELL Function Is NOT Impaired In CLL

The Broad Kinase Inhibitor Dasatinib in Combination with Fludarabine in Patients with Refractory Chronic Lymphocytic Leukemia: A Multicenter Phase 2 Study

ROS-Mediated Upregulation of Noxa Overcomes Drug-Resistance Due to P53-Dysfunction in Chronic Lymphocytic Leukemia.

R-DHAP Is Effective in Fludarabine-Refractory CLL, Possibly Via Upregulation of Pro-Apoptotic P73.

Dichotomy in NF-κb Signaling and Chemoresistance in IgV H Mutated Versus Unmutated CLL Cells Revealed by CD40Ligand/CpG Stimulation

Platinum-Based Compounds Induce Expression of p73 and Restores Drug- Sensitivity in p53 Dysfunctional Chronic Lymphocytic Leukemia (CLL) Cells.

No convincing evidence for a role of CD31-CD38 interactions in the pathogenesis of chronic lymphocytic leukemia

CMV-Associated Expansion of CD8 + CD45RA + CD27 − T-Cells in Patients with B-Cell Malignancies.

CD31-CD38 Interaction Has No Major Role in the Pathogenesis of CLL.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only